Qiagen stock trades unchanged at EUR 40.51 as AI tools expand
Published on 10/10/2026 at 10:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Qiagen traded at EUR 40.51 in weekend trading on October 10, 2026.
- The price was unchanged versus the EUR 40.51 close at Lang & Schwarz on October 9, 2026.
- QIAGEN announced new AI capabilities for research and drug discovery on October 6, 2026.
QIAGEN N.V. announced new artificial intelligence capabilities for research and drug discovery on October 6, 2026, according to the company’s press release. Qiagen stock was EUR 40.51 in weekend trading at Lang & Schwarz at 10:51 a.m. CEST on October 10, 2026, unchanged versus the EUR 40.51 close at Lang & Schwarz on October 9, 2026.
The week in figures
The weekend-trading price was EUR 40.51, with no change against the EUR 40.51 close at Lang & Schwarz on October 9, 2026. The quoted bid was EUR 40.27 and the ask was EUR 40.75. The next Xetra session is scheduled for October 12, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Qiagen stock.
Market context: Market report AEX.
Chronology of the week
On October 6, 2026, QIAGEN announced IPA Investigator and the QIAGEN Discovery Platform. The company said its QIAGEN Digital Insights tools are used by around 150,000 users. The announcement was made by QIAGEN N.V., the listed issuer, and described the platforms as extensions of its bioinformatics offering for research and automated drug-discovery workflows. The company also said the rollout builds on more than 25 years of biomedical knowledge.
Dates of the coming week
The next Xetra session is scheduled for October 12, 2026. No additional dated company event is included here.
